Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF)

European Journal of Radiology

Volumn 81, Issue 5, 2012, Pages 891-896

  Cyran, Clemens C ^a,c   Sennino, Barbara ^a   Fu, Yanjun ^a   Rogut, Victor ^a   Shames, David M ^a   Chaopathomkul, Bundit ^a   Wendland, Michael F ^a   McDonald, Donald M ^a   Brasch, Robert C ^a   Raatschen, Hans Juergen ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Correlation; DCE MRI; Endothelial permeability; Immunohistochemical tumor VEGF levels; Macromolecular contrast media

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; CONTROLLED STUDY; DRUG PENETRATION; DYNAMICS; ENDOTHELIUM; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KINETICS; MACROMOLECULE; MEMBRANE PERMEABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; TUMOR XENOGRAFT;

ANIMALS; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MACROMOLECULAR SUBSTANCES; MAGNETIC RESONANCE IMAGING; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; RATS; RATS, NUDE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84859978243     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2011.07.016     Document Type: Article

References (21)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82(1):4-6. (Pubitemid 20020880)
2. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 2008;11(2):109-19.
3. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9(6):669-76. (Pubitemid 36749215)
4. Jeong AK, Choi SI, Kim DH, et al. Evaluation by contrast-enhanced MR imaging of the lateral border zone in reperfused myocardial infarction in a cat model. Korean J Radiol 2001;2(1):21-7. (Pubitemid 33688941)
5. Cyran CC, Sennino B, Chaopathomkul B, et al. Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers. Eur Radiol 2009;19(1):121-31.
6. Raatschen HJ, Simon GH, Fu Y, et al. Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology 2008;247(2):391-9.
7. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987;22(8):665-71. (Pubitemid 17138432)
8. Schwickert HC, Roberts TP, Shames DM, et al. Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 1995;34(6):845-52.
9. Preda A, Turetschek K, Daldrup H, et al. The choice of region of interest measures in contrast-enhanced magnetic resonance image characterization of experimental breast tumors. Invest Radiol 2005;40(6):349-54. (Pubitemid 40734563)
10. van Dijke CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996;198(3):813-8. (Pubitemid 26066303)
11. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. Pediatr Radiol 1998;28(2):67-78. (Pubitemid 28077437)
12. Cyran CC, Sennino B, Chaopathomkul B, et al. Magnetic resonance imaging assays for dimethyl sulfoxide effect on cancer vasculature. Invest Radiol 2008;43(5):298-305. (Pubitemid 351572206)
13. Inai T, Mancuso M, Hashizume H, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004;165(1):35-52. (Pubitemid 38821812)
14. Scott PA, Gleadle JM, Bicknell R, Harris AL. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer 1998;75(5):706-12. (Pubitemid 28145817)
15. Shulman K, Rosen S, Tognazzi K, Manseau EJ, Brown LF. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases. J Am Soc Nephrol 1996;7(5):661-6. (Pubitemid 27465997)
16. Cyran CC, Fu Y, Raatschen HJ, et al. New macromolecular polymeric MRI contrast agents for application in the differentiation of cancer from benign soft tissues. J Magn Reson Imaging 2008;27(3):581-9. (Pubitemid 351354744)
17. Demsar F, Roberts TP, Schwickert HC, et al. A MRI spatial mapping technique for microvascular permeability and tissue blood volume based on macromolecular contrast agent distribution. Magn Reson Med 1997;37(2):236-42. (Pubitemid 27045396)
18. Daldrup H, Shames DM, Wendland M, et al. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 1998;171(4):941-9. (Pubitemid 28449949)
19. Cai W, Chen X. Multimodality imaging of tumor angiogenesis. J Nucl Med 2008;49:113S-28S.
20. Turetschek K, Preda A, Novikov V, et al. Tumor microvascular changes in antiangiogenic treatment: assessment by magnetic resonance contrast media of different molecular weights. J Magn Reson Imaging 2004;20(1):138-44. (Pubitemid 38857527)
21. Fournier LS, Novikov V, Lucidi V, et al. MR monitoring of cyclooxygenase-2 inhibition of angiogenesis in a human breast cancer model in rats. Radiology 2007;243(1):105-11. (Pubitemid 46579700)